Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

21st Century Cures Act

This page shows the latest 21st Century Cures Act news and features for those working in and with pharma, biotech and healthcare.

Trump talks pricing and manufacturing with pharma

Trump talks pricing and manufacturing with pharma

In particular, there is concern that the orders could effectively stop the 21st Century Cures Act - one of the last actions of the Obama administration and widely welcomed by industry - in

Latest news

  • Bayer helps bankroll new stem cell company BlueRock Bayer helps bankroll new stem cell company BlueRock

    The birth of the new company also comes at an opportune time with the passage in the US of the 21st Century Cures Act, which promises to introduce a truncated registration

  • After Senate vote, Cures Act is en route to Obama for signature After Senate vote, Cures Act is en route to Obama for signature

    law. The US Senate voted 94 to 5 to approve the 21st Century Cures Act, a wide-ranging and controversial bill that will shake up the operations of the FDA and ... The Biotechnology Innovation Organization (BIO), which represents biotech companies,

  • The fifth estate The fifth estate

    Last week, Harvard's T.H. Chan School of Public Health and STAT published the results of a new poll aimed at understanding public opinion on certain provisions of the 21st ... Century Cures Act - specifically the goal of making drug and medical devices

  • Obama to nominate Dr Robert Califf as FDA commissioner Obama to nominate Dr Robert Califf as FDA commissioner

    That experience could serve the agency well as it faces the possibility of considerable changes to its activities under the House of Representatives' proposed 21st Century Cures Act, which, among other

  • Harnessing clinical data Harnessing clinical data

    The 21st Century Cures Act, which recently cleared one of its major hurdles by being approved by the House of Representatives in the US, includes a basket of initiatives aimed at

More from news
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • The evolution of real-world studies The evolution of real-world studies

    Regulatory positions. The growing role of RWE in the US is supported by the 21st Century Cures Act, which led the FDA to create a framework for incorporating RWD into regulatory

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...

Latest intelligence

The 17th World Congress on Controversies in Neurology
This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Tuberculosis – why it remains a major global public health challenge
Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...

Quick links